G01N 2333/96419
Metalloendopeptidases
Official title: Metalloendopeptidases (3.4.24)
G01N2333/96419 (Metalloendopeptidases) appears on 28 US grants and 68 published applications in this corpus.
Search patents in G01N- Granted patents
- 28
- Published applications
- 68
- Assignees
- 57
- Inventors
- 164
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 1 |
| 2012 | 1 | 4 |
| 2013 | 0 | 2 |
| 2014 | 2 | 1 |
| 2015 | 1 | 6 |
| 2016 | 1 | 4 |
| 2017 | 2 | 1 |
| 2018 | 3 | 3 |
| 2019 | 1 | 5 |
| 2020 | 3 | 5 |
| 2021 | 3 | 3 |
| 2022 | 1 | 2 |
| 2023 | 1 | 4 |
| 2024 | 3 | 12 |
| 2025 | 3 | 5 |
| 2026 | 2 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for predicting formation of thrombus or risk of thrombus formation in medical device performing blood circulation by pump31 Mar 2026US 12,590,962 B2Terumo Kabushiki Kaisha
- Ivaltinostat combination therapy for treating pancreatic cancer17 Feb 2026US 12,553,903 B2CG Pharmaceuticals, Inc
- Capture antibody and detection antibody binding MMP9 protein30 Dec 2025US 12,510,542 B1MİMARK Diagnostics, S.L.
- Methods of classifying diffuse large B-cell lymphoma26 Aug 2025US 12,400,737 B2Celgene Corporation
- Pharmaceutical compositions comprising collagenase I and collagenase II1 Apr 2025US 12,263,209 B2ENDO Biologics, Inc.
- Methods and compositions for diangosis of ectopic pregnancy10 Sep 2026US 2026/0266840 A1The Trustees of the University of Pennsylvania
- Adamts12 as a target molecule for the treatment of chronic renal insufficiency and renal fibrosis16 Jul 2026US 2026/0202408 A1Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
- Method of detecting cancer biomarker concentration or detecting exosome concentration of in vitro biological sample with magnetic janus particle conjugated with detecting antibody18 Jun 2026US 2026/0168999 A1National Cheng Kung University
- Protease-cleavable moieties and methods of use thereof12 Feb 2026US 2026/0042849 A1CytomX Therapeutics, Inc.
- Mmp-14 or timp potency assay for mesenchymal stem cells15 Jan 2026US 2026/0014205 A1Longeveron Inc.
Most cited
By later US patents
- Clostridium histolyticum enzymes and methods for the use thereof15US 9,757,435 B2Endo Global Ventures · 2017
- Salivary inflammatory biomarkers associated with glycemic control and oral health7US 9,753,041 B2Univeristy of South Florida · 2017
- Clostridium histolyticum enzymes and methods for the use thereof6US 10,603,365 B2Endo Global Ventures · 2020
- In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject4US 10,907,135 B2Centro Nacional De Investigaciones Cardiovasculares Carlos III (F.S.P.) · 2021
- System for determining unprocessed and partially processed neurotoxin type A2US 8,841,080 B2MERZ PHARMA GmbH & CO. KGaA · 2014